Report Detail

Summary

World trade was already slowing in 2019 before COVID 19 outbreak, weighed down by trade tensions and slowing economic growth, such as uncertainty generated from Brexit, the U.S.-China trade war, the Japan-South Korea trade war.

Trade is expected to fall by between 13% and 32% in 2020 as the COVID 19 pandemic disrupts normal economic activity and life around the world, according to the study of WTO.The decline in exports has been mainly due to the ongoing global slowdown, which got aggravated due to the current Covid-19 crisis. The latter resulted in large scale disruptions in supply chains and demand resulting in cancellation of orders.

XYZResearch’s analysis shows that as China started reopening its economy, world exports initially recovered across the board. But estimates of the expected recovery in 2021 are uncertain, with outcomes depending largely on the duration of the outbreak and the effectiveness of the policy responses.

This research report indicated that the global Coartem (Artemether/Lumefantrine) market was valued at USD XXX million in 2019, and it is expected to reach a value of USD XXX million by 2026, at a CAGR of XX % over the forecast period 2021-2026. In terms of the export, China occupied more than XX % export market share in 2019, India occupied XX %. XXX is the second largest region around the world, it occupied about XX % export market share in 2019. In terms of the Local Capacity, XXX is the largest region around the world, it occupied about XX % export market share in 2019.

Regional Segmentation (Value; Revenue, USD Million, 2015 - 2026) of Coartem (Artemether/Lumefantrine) Market by XYZResearch Include
China
EU
North America
Japan
India
Southeast Asia
South America
Middle East and Africa
Competitive Analysis; Who are the Major Players in Coartem (Artemether/Lumefantrine) Market?
Novartis
Sanofi-Aventis
KPC Pharmaceuticals, Inc
Guangxi Xiancaotang Pharmaceutical Co., LTD
Guilin Pharmaceutical Co., Ltd
Kerui Nanhai Pharmaceutical
Kunming Pharmaceutical
...
...
Major Type of Coartem (Artemether/Lumefantrine) Covered in XYZResearch report:
Artemether
Lumefantrine
Application Segments Covered in XYZResearch Market
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

For any other requirements, please feel free to contact us and we will provide you customized report.


Table of Contents

    Global Coartem (Artemether/Lumefantrine) Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin

      1 Market Scope

      • 1.1 Product Details and Introduction
        • 1.1.1 Artemether -Product Introduction and Major Manufacturers
        • 1.1.2 Lumefantrine -Product Introduction and Major Manufacturers
      • 1.2 Market Snapshot
        • 1.2.1 Major Companies Overview
        • 1.2.2 Market Concentration
        • 1.2.3 Six-Year Compound Annual Growth Rate (CAGR)

      2 Regional Market Analysis

      • 2.1 China Coartem (Artemether/Lumefantrine) Status and Prospect (2016-2027)
        • 2.1.1 China Coartem (Artemether/Lumefantrine) Market Size and Growth Rate (2016-2027)
        • 2.1.2 China Coartem (Artemether/Lumefantrine) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.2 EU Coartem (Artemether/Lumefantrine) Status and Prospect (2016-2027)
        • 2.2.1 EU Coartem (Artemether/Lumefantrine) Market Size and Growth Rate (2016-2027)
        • 2.2.2 EU Coartem (Artemether/Lumefantrine) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.3 USA Coartem (Artemether/Lumefantrine) Status and Prospect (2016-2027)
        • 2.3.1 USA Coartem (Artemether/Lumefantrine) Market Size and Growth Rate (2016-2027)
        • 2.3.2 USA Coartem (Artemether/Lumefantrine) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.4 Japan Coartem (Artemether/Lumefantrine) Status and Prospect (2016-2027)
        • 2.4.1 Japan Coartem (Artemether/Lumefantrine) Market Size and Growth Rate (2016-2027)
        • 2.4.2 Japan Coartem (Artemether/Lumefantrine) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.5 India Coartem (Artemether/Lumefantrine) Status and Prospect (2016-2027)
        • 2.5.1 India Coartem (Artemether/Lumefantrine) Market Size and Growth Rate (2016-2027)
        • 2.5.2 India Coartem (Artemether/Lumefantrine) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.6 Southeast Asia Coartem (Artemether/Lumefantrine) Status and Prospect (2016-2027)
        • 2.6.1 Southeast Asia Coartem (Artemether/Lumefantrine) Market Size and Growth Rate (2016-2027)
        • 2.6.2 Southeast Asia Coartem (Artemether/Lumefantrine) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.7 South America Coartem (Artemether/Lumefantrine) Status and Prospect (2016-2027)
        • 2.7.1 South America Coartem (Artemether/Lumefantrine) Market Size and Growth Rate (2016-2027)
        • 2.7.2 South America Coartem (Artemether/Lumefantrine) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)
      • 2.8 Coartem (Artemether/Lumefantrine) Status and Prospect (2016-2027)
        • 2.8.1 Coartem (Artemether/Lumefantrine) Market Size and Growth Rate (2016-2027)
        • 2.8.2 Coartem (Artemether/Lumefantrine) Local Capacity, Import, Export, Local Consumption Analysis (2015-2020)

      3 Global Coartem (Artemether/Lumefantrine) Market Assessment by Segment

      • 3.1 Global Coartem (Artemether/Lumefantrine) Capacity and Growth Rate
      • 3.2 Global Coartem (Artemether/Lumefantrine) Sales by Type
      • 3.3 Global Coartem (Artemether/Lumefantrine) Sales Revenue by Type
      • 3.4 Global Coartem (Artemether/Lumefantrine) Consumption by Application

      4 Global Coartem (Artemether/Lumefantrine) Market Assessment by Regions

      • 4.1 Global Coartem (Artemether/Lumefantrine) Production Analysis and Forecast by Regions (2016-2027)
      • 4.2 Global Coartem (Artemether/Lumefantrine) Sales Analysis and Forecast by Regions (2016-2027)
      • 4.3 Global Coartem (Artemether/Lumefantrine) Sales Revenue Analysis and Forecast by Regions (2016-2027)

      5 Value Chain (Impact of COVID-19)

      • 5.1 Coartem (Artemether/Lumefantrine) Value Chain Analysis
        • 5.1.1 Upstream
        • 5.1.2 Downstream
      • 5.2 COVID-19 Impact on Coartem (Artemether/Lumefantrine) Industry
        • 5.2.1 Industrial Policy Issued Under the Epidemic Situation
      • 5.3 Cost-Under the Epidemic Situation
        • 5.3.1 Cost of Raw Material
      • 5.4 Channel Analysis
        • 5.4.1 Distribution Channel-Under the Epidemic Situation
        • 5.4.2 Distributors

      6 Competitive Landscape

      • 6.1 Global Coartem (Artemether/Lumefantrine) Capacity Market Share of Manufacturers (2019-2020)
      • 6.2 Global Coartem (Artemether/Lumefantrine) Sales Market Share of Manufacturers (2019-2020)
      • 6.3 Global Coartem (Artemether/Lumefantrine) Sales Revenue Market Share of Manufacturers (2019-2020)

      7 Coartem (Artemether/Lumefantrine) Competitive Analysis

      • 7.1 Novartis
        • 7.1.1 Novartis Company Profiles
        • 7.1.2 Novartis Product Introduction
        • 7.1.3 Novartis Coartem (Artemether/Lumefantrine) Production, Revenue (2015-2020)
        • 7.1.4 SWOT Analysis
      • 7.2 Sanofi-Aventis
        • 7.2.1 Sanofi-Aventis Company Profiles
        • 7.2.2 Sanofi-Aventis Product Introduction
        • 7.2.3 Sanofi-Aventis Coartem (Artemether/Lumefantrine) Production, Revenue (2015-2020)
        • 7.2.4 SWOT Analysis
      • 7.3 KPC Pharmaceuticals, Inc
        • 7.3.1 KPC Pharmaceuticals, Inc Company Profiles
        • 7.3.2 KPC Pharmaceuticals, Inc Product Introduction
        • 7.3.3 KPC Pharmaceuticals, Inc Coartem (Artemether/Lumefantrine) Production, Revenue (2015-2020)
        • 7.3.4 SWOT Analysis
      • 7.4 Guangxi Xiancaotang Pharmaceutical Co., LTD
        • 7.4.1 Guangxi Xiancaotang Pharmaceutical Co., LTD Company Profiles
        • 7.4.2 Guangxi Xiancaotang Pharmaceutical Co., LTD Product Introduction
        • 7.4.3 Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether/Lumefantrine) Production, Revenue (2015-2020)
        • 7.4.4 SWOT Analysis
      • 7.5 Guilin Pharmaceutical Co., Ltd
        • 7.5.1 Guilin Pharmaceutical Co., Ltd Company Profiles
        • 7.5.2 Guilin Pharmaceutical Co., Ltd Product Introduction
        • 7.5.3 Guilin Pharmaceutical Co., Ltd Coartem (Artemether/Lumefantrine) Production, Revenue (2015-2020)
        • 7.5.4 SWOT Analysis
      • 7.6 Kerui Nanhai Pharmaceutical
        • 7.6.1 Kerui Nanhai Pharmaceutical Company Profiles
        • 7.6.2 Kerui Nanhai Pharmaceutical Product Introduction
        • 7.6.3 Kerui Nanhai Pharmaceutical Coartem (Artemether/Lumefantrine) Production, Revenue (2015-2020)
        • 7.6.4 SWOT Analysis
      • 7.7 Kunming Pharmaceutical
        • 7.7.1 Kunming Pharmaceutical Company Profiles
        • 7.7.2 Kunming Pharmaceutical Product Introduction
        • 7.7.3 Kunming Pharmaceutical Coartem (Artemether/Lumefantrine) Production, Revenue (2015-2020)
        • 7.7.4 SWOT Analysis
      • 7.8 ...
        • 7.8.1 ... Company Profiles
        • 7.8.2 ... Product Introduction
        • 7.8.3 ... Coartem (Artemether/Lumefantrine) Production, Revenue (2015-2020)
        • 7.8.4 SWOT Analysis

      8 Conclusion

      Summary:
      Get latest Market Research Reports on Coartem (Artemether/Lumefantrine). Industry analysis & Market Report on Coartem (Artemether/Lumefantrine) is a syndicated market report, published as Post-pandemic Era-Global Coartem (Artemether/Lumefantrine) Market 2016-2027, With Breakdown Data of Capacity, Sales, Production, Export, Import, Revenue, Price, Cost and Gross Margin. It is complete Research Study and Industry Analysis of Coartem (Artemether/Lumefantrine) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,620.00
      $5,500.00
      2,888.76
      4,389.00
      3,381.08
      5,137.00
      565,697.40
      859,485.00
      302,233.80
      459,195.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report